Anesthesia Pharmacology: Histamine and Bradykinin
Practice Questions
Click on the correct answer.
1 / 10
Administration of this agent is less likely to result in cytochrome P450-related drug-drug interaction
Cimetidine
Ranitidine
Vagal postganglionic nerve-mediated acetylcholine release and subsequent acetylcholine binding to parietal cell receptors cause an increase in cytosolic calcium thus activating protein kinases which cause increased acid secretion utilizing a proton pump, the H+/K+-ATPase.
True
False
Gastrointestinal parietal cells express which one(s) of the following receptors, the activation of which results in acid secretion?
Gastrin
Acetylcholine
Histamine (H2)
A & B
A, B & C
Enterochromaffin-like (ECL) cells stimulate histamine release following activation of this/these receptor(s):
Acetylcholine
Gastrin
Both
Neither
For patients at risk of bleeding from stress-related gastritis and absent a nasoenteric tube, which one of the following options appear preferable
Intravenous proton pump inhibitor
Intravenous H2-histamine receptor blockers
Clinical uses of H2-histamine receptor blockers include/includes:
Peptic ulcer disease
Gastroesophageal reflux disease (Gerd)
Nonulcer dyspepsia
Prevention of bleeding in gastritis (stress-related)
A & B
B & C
A, B, C & D
Most (greater than 90%) of peptic ulcers are due to:
Use of nonsteroidal anti-inflammatory agents (NSAIDs)
Helicobacter Pylorii (H Pylorii) infection
Both
Neither
Effective agent(s) in decreasing the likelihood of clinically important bleeding in stress-related gastritis.
Proton pump inhibitor
H2-histamine receptor antagonist
Both
Neither
Both antacids and H2-histamine receptor antagonists are helpful in managing infrequent heartburn/dyspepsia.
True
False
Administration of H2-histamine receptor blockers results in noncompetitive inhibition at parietal cell H2-histamine receptors and suppress only basal, not meal-stimulated acid secretion.